NervGen Pharma Stock Forecast

Stock Price Forecast

The 5 analysts with 12-month price forecasts for NervGen Pharma stock have an average target of 11.9, with a low estimate of 5.50 and a high estimate of 18. The average target predicts an increase of 536.36% from the current stock price of 1.87.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$5.50	$11.9	$12	$18
Change	+194.12%	+536.36%	+541.71%	+862.57%

Analyst Ratings

The average analyst rating for NervGen Pharma stock from 7 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	1	1	1	3	2	3
Buy	3	2	3	4	4	4
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	3	4	7	6	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Ram Selvaraju H.C. Wainwright	H.C. Wainwright	Buy Reiterates $18	Buy	Reiterates	$18	+862.57%	Jun 25, 2026
Joseph Thome TD Cowen	TD Cowen	Buy Initiates n/a	Buy	Initiates	n/a	n/a	Jun 11, 2026
Justin Keywood Stifel Nicolaus	Stifel Nicolaus	Buy Reiterates $6	Buy	Reiterates	$6	+220.86%	May 21, 2026
Elemer Piros Lucid Capital	Lucid Capital	Buy Initiates $18	Buy	Initiates	$18	+862.57%	Apr 15, 2026
Andre Uddin Research Capital	Research Capital	Buy Maintains $5.5	Buy	Maintains	$5.5	+194.12%	Apr 10, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-0.26

from -0.44

EPS Next Year

-0.38

from -0.26

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	-	-	-	-	-	-
Revenue Growth	-	-	-	-	-	-	-
EPS	-0.32	-0.39	-0.38	-0.36	-0.61	-0.26	-0.37
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	5	5

Financial currency is CAD. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	n/a	n/a
Avg	n/a	n/a
Low	n/a	n/a

Revenue Growth

Revenue Growth	2027	2028
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2026	2027
High	-0.23	-0.27
Avg	-0.26	-0.38
Low	-0.29	-0.49

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.